Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152684 · ClinicalTrials.gov registry record
Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
A clinical trial of HIV Positive, sponsored by University of California, San Diego.
- Completed
- Registry status
- 541
- Enrollment target
- 1
- Study location
NCT01152684: Completed study of HIV Positive, sponsored by University of California, San Diego.
NCT01152684 is a study of HIV Positive that has completed, run by University of California, San Diego. The registered enrollment target is 541 participants, roughly in line with the 495-participant average among 3 other HIV Positive trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01152684, a study of HIV Positive, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 541 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of The investigators community-based participatory research study is to identify the nature and extent of complementary and alternative medicine (CAM) use among HIV-positive Latinos on the San Diego/Tijuana border. CAM use among US Latinos living with HIV is associated with delayed utilization of and poor adherence to antiretroviral therapies (ARVs) that may exacerbate health disparities in HIV care access and health outcomes. This study will lead to development of culturally-effective interventions to improve access and adherence to HIV care in Latinos who face health disparities. The investigators hypothesis is that greater use of CAM will be observed among HIV-positive Latinos who report a) crossing the U.S. border more frequently, and b) having migrated to Tijuana or San Diego (e.g. from southern Mexico). The investigators also hypothesize that compared to HIV-positive Latinos who report using herbal CAM, those who do not use herbal CAM are more likely to be receiving ARVs and report higher levels of adherence to ARVs; Compared to HIV-positive Latinos who do not attend religious services regularly, those who attend religious services regularly are more likely to be receiving ARV; Compared to HIV- positive Latinos who report experiencing HIV related stigma, those who do not report experiencing HIV-related stigma are significantly more likely to be receiving ARVs.
Conditions Studied
Study Locations (1)
California
- San Ysidro Health Center - San Ysidro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-01 |
What the finished NCT01152684 record still lists
NCT01152684 is an observational study that tracks outcomes without assigning an intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 495-participant average among 3 other HIV Positive trials with a reported enrollment target.
The record links to 1 condition, with HIV Positive appearing as the primary indexed condition, and to 0 interventions.
NCT01152684 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01152684 about?
NCT01152684 is a clinical study titled "Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border". The goal of The investigators community-based participatory research study is to identify the nature and extent of complementary and alternative medicine (CAM) use among HIV-positive Latinos on the San Diego/Tijuana border. CAM use among US Latinos living with HIV is associated with delayed utilizat...
What is the current status of trial NCT01152684?
This trial is currently completed. The enrollment target is 541 participants. The study started on 2009-09. Estimated completion is 2013-01.
What conditions does trial NCT01152684 study?
This clinical trial studies the following conditions: HIV Positive.
Who is sponsoring clinical trial NCT01152684?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01152684 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Positive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia